Date	Period	Revenue/Estimate	Earnings Call
Nov 10, 2022	2022/Q3	9.153M / 10.675M	--
Aug 3, 2022	2022/Q2	9.191M / 8.530M	--
May 5, 2022	2022/Q1	8.020M / 9.575M	--
Mar 29, 2022	2021/Q4	9.261M / 10.099M	--
Nov 9, 2021	2021/Q3	8.862M / 7.463M	--

DatePeriodRevenue/EstimateEarnings Call

Nov 10, 20222022/Q39.153M / 10.675M--

Aug 3, 20222022/Q29.191M / 8.530M--

May 5, 20222022/Q18.020M / 9.575M--

Mar 29, 20222021/Q49.261M / 10.099M--

Nov 9, 20212021/Q38.862M / 7.463M--

Unlock Free Earnings Estimates

Open Account

Nabriva Therapeutics PLC | 10-Q: Q2 2023 Earnings Report

Oct 18, 2023 17:57 ET

Nabriva Therapeutics | 10-Q: Q1 2023 Earnings Report

May 22, 2023 16:01 ET

Nabriva Therapeutics | 10-K: FY2022 Annual Report

Apr 17, 2023 16:15 ET

Nabriva Therapeutics | 8-K: Nabriva Therapeutics Pivoting Strategic Focus Reports Third Quarter Financial Results and Provides Corporate Update

Nov 10, 2022 16:08 ET

NBRVF Nabriva Therapeutics PLC

Nabriva Therapeutics PLC Key Stats